These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 20889945)

  • 21. Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands.
    Holleboom CA; van Eyck J; Koenen SV; Kreuwel IA; Bergwerff F; Creutzberg EC; Bruinse HW
    Arch Gynecol Obstet; 2013 Jun; 287(6):1111-7. PubMed ID: 23329341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
    Chaudhuri P; Banerjee GB; Mandal A
    Int J Gynaecol Obstet; 2010 Apr; 109(1):25-9. PubMed ID: 20070961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal hemodynamics after oxytocin bolus compared with infusion in the third stage of labor: a randomized controlled trial.
    Davies GA; Tessier JL; Woodman MC; Lipson A; Hahn PM
    Obstet Gynecol; 2005 Feb; 105(2):294-9. PubMed ID: 15684155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oxytocin for the prophylaxis of uterine atony after cesarean delivery. Should we reconsider our protocols?].
    Schiraldi R; Guasch E
    Rev Esp Anestesiol Reanim; 2014; 61(7):359-61. PubMed ID: 24924341
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
    Owonikoko KM; Arowojolu AO; Okunlola MA
    J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose.
    Cordovani D; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2012 Aug; 59(8):751-7. PubMed ID: 22717890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest.
    Balki M; Dhumne S; Kasodekar S; Kingdom J; Windrim R; Carvalho JC
    BJOG; 2008 Apr; 115(5):579-84. PubMed ID: 18333937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
    Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
    Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized, Double-blinded Trial of a "Rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery.
    Kovacheva VP; Soens MA; Tsen LC
    Anesthesiology; 2015 Jul; 123(1):92-100. PubMed ID: 25909969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.
    Badejoko OO; Ijarotimi AO; Awowole IO; Loto OM; Badejoko BO; Olaiya DS; Fatusi AO; Kuti O; Orji EO; Ogunniyi SO
    J Obstet Gynaecol Res; 2012 Nov; 38(11):1294-301. PubMed ID: 22612662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial.
    Sheehan SR; Montgomery AA; Carey M; McAuliffe FM; Eogan M; Gleeson R; Geary M; Murphy DJ;
    BMJ; 2011 Aug; 343():d4661. PubMed ID: 21807773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery.
    Wetta LA; Szychowski JM; Seals S; Mancuso MS; Biggio JR; Tita AT
    Am J Obstet Gynecol; 2013 Jul; 209(1):51.e1-6. PubMed ID: 23507549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage.
    Jackson KW; Allbert JR; Schemmer GK; Elliot M; Humphrey A; Taylor J
    Am J Obstet Gynecol; 2001 Oct; 185(4):873-7. PubMed ID: 11641669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section.
    Dansereau J; Joshi AK; Helewa ME; Doran TA; Lange IR; Luther ER; Farine D; Schulz ML; Horbay GL; Griffin P; Wassenaar W
    Am J Obstet Gynecol; 1999 Mar; 180(3 Pt 1):670-6. PubMed ID: 10076146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of controlled studies investigating the risk of postpartum haemorrhage in cesarean delivery after prior use of oxytocin: a scoping review.
    Bischoff K; Nothacker M; Lehane C; Lang B; Meerpohl J; Schmucker C
    BMC Pregnancy Childbirth; 2017 Nov; 17(1):399. PubMed ID: 29187156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buccal misoprostol to prevent hemorrhage at cesarean delivery: a randomized study.
    Hamm J; Russell Z; Botha T; Carlan SJ; Richichi K
    Am J Obstet Gynecol; 2005 May; 192(5):1404-6. PubMed ID: 15902121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
    Vimala N; Mittal S; Kumar S
    Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery--a double-blind randomised controlled trial.
    Su LL; Rauff M; Chan YH; Mohamad Suphan N; Lau TP; Biswas A; Chong YS
    BJOG; 2009 Oct; 116(11):1461-6. PubMed ID: 19538418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
    Fujimoto M; Takeuchi K; Sugimoto M; Maruo T
    Acta Obstet Gynecol Scand; 2006; 85(11):1310-4. PubMed ID: 17091409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
    Chaudhuri P; Mandi S; Mazumdar A
    J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.